PoliticsWorld NEWS

Pfizer targets obesity with new once-daily danuglipron drug

Pfizer announced that it has selected its preferred once-daily modified release formulation of danuglipron, a move that is significant in the obesity drug’s development.Read More US 

Show More

Related Articles

Back to top button
WP Twitter Auto Publish Powered By : XYZScripts.com

Adblock Detected

Please, turn off your Ad-blocker